Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

NUCLEAR FACTOR KAPPA B PATHWAY INHIBITOR COMPOSITION AND USE OF SAME

  • Read more about NUCLEAR FACTOR KAPPA B PATHWAY INHIBITOR COMPOSITION AND USE OF SAME
US Application 61/098,977
Filed on 2008-09-22

Method For Detection Of Cancer Based On Spatial Genome Organization

  • Read more about Method For Detection Of Cancer Based On Spatial Genome Organization
US Application 61/094,318
Filed on 2008-09-04

GENE EXPRESSION SIGNATURE PREDICTIVE RESPONSE TO CHEMOTHERAPY

  • Read more about GENE EXPRESSION SIGNATURE PREDICTIVE RESPONSE TO CHEMOTHERAPY
US Application 61/195,123
Filed on 2008-10-03

HTLV-II Based Vector For An HIV Vaccine

  • Read more about HTLV-II Based Vector For An HIV Vaccine
US Application 61/081,994
Filed on 2008-07-18

A Method Of Treating Tumors With Armed And Unarmed Monoclonal
Antibodies Or Their Fragments Reactive With Chondroitin Proteoglycan Sulfate (MEL-14 ScFv)

  • Read more about A Method Of Treating Tumors With Armed And Unarmed Monoclonal Antibodies Or Their Fragments Reactive With Chondroitin Proteoglycan Sulfate (MEL-14 ScFv)
US Application 61/071,110
Filed on 2008-04-11

APOGOSSYPOL ATROPOISOMERS AND METHODS OF PREPARING THEREOF

  • Read more about APOGOSSYPOL ATROPOISOMERS AND METHODS OF PREPARING THEREOF
US Application 61/053,521
Filed on 2008-05-15

MATERIALS AND METHODS FOR IDENTIFYING PATIENTS AT HEIGHTEN RISK FOR DEVELOPING HER2+ RELATED BRAIN TUMORS

  • Read more about MATERIALS AND METHODS FOR IDENTIFYING PATIENTS AT HEIGHTEN RISK FOR DEVELOPING HER2+ RELATED BRAIN TUMORS
US Application 61/057,828
Filed on 2008-05-31

Design And Synthesis Of Aromatecin Derivatives And Their Identification As Topoisomerase 1 Inhibitors And Anti-cancer Agents65107.00.WO

  • Read more about Design And Synthesis Of Aromatecin Derivatives And Their Identification As Topoisomerase 1 Inhibitors And Anti-cancer Agents65107.00.WO
US Application 61/053,338
Filed on 2008-05-15

Survival Predictor For Diffuse Large B Cell Lymphoma

  • Read more about Survival Predictor For Diffuse Large B Cell Lymphoma
US Application 61/059,678
Filed on 2008-06-06

In Vivo Quantitative Tissue Oxygen Imaging Using Pulsed Time-Domain Electron Paramagnetic Resonance Using A Combination Of Electron Spin-Echo And Single Point Imaging - ESPI (Echo-based Single Point Imaging)

  • Read more about In Vivo Quantitative Tissue Oxygen Imaging Using Pulsed Time-Domain Electron Paramagnetic Resonance Using A Combination Of Electron Spin-Echo And Single Point Imaging - ESPI (Echo-based Single Point Imaging)
US Application 61/200,579
Filed on 2008-11-29

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 126
  • Page 127
  • Page 128
  • Page 129
  • Page 130
  • Page 131
  • Page 132
  • Page 133
  • Page 134
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health